Doko MD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: people who want a published per-dose price for compounded semaglutide or tirzepatide and phone support
Doko MD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. It charges from $94 a month; its compounded semaglutide, at $116, is 42% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Charged on top
Lab work
Not stated
Coaching
Not stated
Prices checked November 2026
Doko MD is a Texas telehealth company that offers online visits for diabetes, urgent care and other needs, plus a cash-pay weight-loss program with compounded semaglutide and tirzepatide. Each four-week supply is priced by dose, from $94 for semaglutide and $116 for tirzepatide, and refills automatically. The order form adds a $39.99 intake review and $35 shipping to the first order.
Is Doko MD legit?
Yes. Doko MD is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.7/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Doko MD promo or coupon code?
We know of no promo or coupon code for Doko MD. Its listed price is $94 a month. Coupon sites advertising "Doko MD discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Doko MD compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Doko MD
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Doko MD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $94/mo
- Pricing model
- Rises with the dose: higher doses cost more
- What's included
- Medication
- FDA status
- No FDA warning letters found
How Doko MD scores
Six columns, each one computed from something Doko MD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
8.9/10$116/month is 42% below the $199 median for compounded semaglutide across the sellers we compare. A cheaper starter price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
3.0/10The price covers the medication.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Doko MD
Last checked November 2026- Checked the listed price across 4 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Doko MD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Doko MD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Doko MD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Doko MD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication.
- Lowest ongoing monthly price: semaglutide $94, tirzepatide $116. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Doko MD serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Doko MD
- Phone
- 1 (888) 904-3656
- Doko MD offers email support
Cancelling Doko MD
Taken from the terms Doko MD publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None stated; each four-week supply refills automatically until you cancel
- Refund policy
- Refund Policy: "For medication, we are unable to accept returns or offer refunds due to government regulation." Defective or damaged items are replaced.
Medications Doko MD lists
Doko MD lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Drug page: "$94 FOUR-WEEK SUPPLY 0.25mg 4 weekly doses Shipping and consultation extra". Order form: "Medication $94.00 Clinician Intake Review & Evaluation $39.99 Shipping $35.00 Order total $168.99".
Dose ladder: 0.25 mg $94, 0.5 mg $99, 1.0 mg $105, 1.7 mg $111, 2.4 mg $116, each a four-week supply.
Drug page: "Medication starts at $116 for the 2.5 mg starter tier. Checkout adds $35 shipping and a separate consultation fee." Order form total for this dose: $190.99.
Dose ladder: 2.5 mg $116, 5 mg $128, 7.5 mg $139, 10 mg $151, 12.5 mg $162, 15 mg $168, each a four-week supply.
Check the price yourself before you pay
Every figure here comes from Doko MD's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $116 a month, 42% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $168 a month, 38% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- We found no FDA warning letters issued to Doko MD
Against it
- Not included in the monthly price: clinician visits, shipping
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Doko MD charges
The standing price at Doko MD is $94/month.
- Compounded semaglutide (starter): $94/month
- Compounded semaglutide: $116/month
- Compounded tirzepatide (starter): $116/month
- Compounded tirzepatide: $168/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Doko MD's $116 is genuinely below the middle, not just advertised that way. Before you pay, compare Doko MD's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
AgelessRx, at about $99/month, is the closest like-for-like alternative we review.
What Doko MD dispenses
Doko MD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Doko MD tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to Doko MD. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Doko MD will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Doko MD bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
Doko MD competes on price without an obvious sacrifice elsewhere: $116/month for compounded semaglutide, no FDA warning letters.
The Bottom Line
Doko MD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. It charges from $94 a month; its compounded semaglutide, at $116, is 42% below the $199 median among the sellers we compare.
Before you pay Doko MD
Starting at $94 a month. Check today's price, then start the intake.
Where Doko MD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Doko MD sets more sellers in the same category beside Doko MD on price, states and what the price includes.
Frequently Asked Questions
How to check Doko MD yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Doko MD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Doko MD's current pricing
Plans start at $94 a month. Whether you qualify is a clinician's decision, made after your intake.